The International Conference of Drug Regulatory Authorities (ICDRA) is a World Health Organization forum that convenes national medicines regulators to promote collaboration and regulatory convergence.
ICDRA discussions can influence international norms around pharmacovigilance, inspection approaches, and regulatory science priorities. For sponsors running global trials, convergence outcomes may shape expectations for safety reporting, data standards, and oversight practices across regions. The forum supports shared learning on emerging risks and regulatory modernization. Participation and awareness help sponsors anticipate evolving expectations and align global compliance strategies.